INTRODUCTION: Adults with Down syndrome (DS) have a higher risk of Alzheimer's disease (AD). As gut microbiota (GM) alterations have been reported in AD, we investigated their association with cognitive decline and plasma AD biomarkers in DS. METHODS: Fecal and plasma samples were collected from 58 adults with DS (21–75 years) and 30 euploid controls (CTRL; 25–83 years). GM was profiled using 16S rRNA sequencing, filtering low prevalent taxa. Major neurocognitive disorder (NcD) was diagnosed with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. Plasma levels of phosphorylated tau 181 (p-tau181), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were measured using Simoa. RESULTS: DS showed no changes in overall microbial diversity compared to CTRL, but genera including UBA1819 and Intestinibacter were altered. Specific genera showed changes in DS with NcD, like Alistipes (increased) and Roseburia (decreased), with the latter negatively associated with plasma AD biomarkers. DISCUSSION: Adults with DS display AD-associated changes in GM partially resembling those reported previously in euploid AD patients.

Pellegrini, C., Ravaioli, F., De Fanti, S., Siliquini, A., Sala, C., Rochat, M., et al. (2026). Alterations of gut microbiota in Down syndrome and their association with Alzheimer's disease. ALZHEIMER'S & DEMENTIA, 22(9), e71815-e71815 [10.1002/alz.71815].

Alterations of gut microbiota in Down syndrome and their association with Alzheimer's disease

Sala, Claudia;Cortelli, Pietro;Provini, Federica;Lodi, Raffaele;Morandi, Luca;Parchi, Piero;Tonon, Caterina;Bacalini, Maria Giulia
2026

Abstract

INTRODUCTION: Adults with Down syndrome (DS) have a higher risk of Alzheimer's disease (AD). As gut microbiota (GM) alterations have been reported in AD, we investigated their association with cognitive decline and plasma AD biomarkers in DS. METHODS: Fecal and plasma samples were collected from 58 adults with DS (21–75 years) and 30 euploid controls (CTRL; 25–83 years). GM was profiled using 16S rRNA sequencing, filtering low prevalent taxa. Major neurocognitive disorder (NcD) was diagnosed with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. Plasma levels of phosphorylated tau 181 (p-tau181), neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were measured using Simoa. RESULTS: DS showed no changes in overall microbial diversity compared to CTRL, but genera including UBA1819 and Intestinibacter were altered. Specific genera showed changes in DS with NcD, like Alistipes (increased) and Roseburia (decreased), with the latter negatively associated with plasma AD biomarkers. DISCUSSION: Adults with DS display AD-associated changes in GM partially resembling those reported previously in euploid AD patients.
2026
Pellegrini, C., Ravaioli, F., De Fanti, S., Siliquini, A., Sala, C., Rochat, M., et al. (2026). Alterations of gut microbiota in Down syndrome and their association with Alzheimer's disease. ALZHEIMER'S & DEMENTIA, 22(9), e71815-e71815 [10.1002/alz.71815].
Pellegrini, Camilla; Ravaioli, Francesco; De Fanti, Sara; Siliquini, Alessia; Sala, Claudia; Rochat, Magali; Pollarini, Virginia; Polischi, Barbara; P...espandi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1091110
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex ND
social impact